Order results by:
| Issue | Title | |
| Vol 11, No 1 (2018) | Methods of clinical assessment from the “Clinical Recommendations” resource of the Ministry of Healthcare of Russia: a systematic review | Abstract similar documents |
| V. M. Vatolin, O. A. Sukhorukikh, Zh. A. Galeeva, D. V. Lukyantseva, O. O. Buzuverova, O. V. Kirsanova, E. M. Murtazina, D. G. Ilyukhin, L. S. Shubina | ||
| "... evaluation, e. g. scores, indices, questionnaires and other approaches that appear in the clinical guidelines ..." | ||
| Vol 12, No 1 (2019) | The use of the level of evidence and grade of recommendations scales in developing clinical guidelines in the Russian Federation | Abstract similar documents |
| N. I. Zhuravleva, L. C. Shubina, O. A. Sukhorukikh | ||
| "... of recommendation (GR-scales) in the development of clinical guidelines in the Russian Federation. Materials ..." | ||
| Vol 13, No 3 (2020) | Regulatory framework of the oncological medical care provision | Abstract similar documents |
| S. N. Tishkina, V. E. Matskevich, Yu. A. Ledovskikh, E. V. Semakova, V. V. Omelyanovskiy | ||
| "... , regulatory documents on clinical guidelines and standards of medical care. Results. The content analysis ..." | ||
| Vol 12, No 3 (2019) | Regulatory and legal status of clinical guidelines and their role in the quality control of medical care in countries of the European Union, North America and Asia | Abstract similar documents |
| V. K. Fedyaeva , U. N. Dmitrieva , N. I. Juravleva , N. I. Juravlev , M. Yu. Kovaleva , A. S. Korobkina , O. A. Sukhorukikh , A. A. Pashkina | ||
| "... Introduction. In 2016-2018, the approaches to the development and use of clinical guidelines ..." | ||
| Vol 12, No 2 (2019) | New framework for the development of clinical guidelines in Russia | Abstract similar documents |
| D. V. Blinov, E. S. Akarachkova, A. S. Orlova, E. V. Kryukov, D. I. Korabelnikov | ||
| "... the methodology for the development of clinical guidelines (CG) that meet the requirements of the legislation ..." | ||
| Vol 12, No 4 (2019) | Developing clinical guidelines and assessing the quality of medical care using the RAND/UCLA method | Abstract similar documents |
| O. O. Buzuverova, V. K. Fedyaeva, O. A. Sukhorukikh | ||
| "... , the RAND/UCLA method is internationally used to develop clinical guidelines, criteria for assessing ..." | ||
| Vol 16, No 1 (2023) | Principles of medical care standards development based on clinical guidelines | Abstract similar documents |
| Yu. A. Ledovskikh, S. N. Tishkina, G. I. Pirova, E. V. Semakova, V. V. Omelyanovskiy | ||
| "... the development of medical care standards based on clinical guidelines was performed. Results. The procedure ..." | ||
| Vol 16, No 2 (2023) | Key principles of drug therapy in patients with chronic myeloid leukemia | Abstract similar documents |
| A. V. Zhuravlev, O. I. Knysh | ||
| "... and methods. The basis of the study included modern scientific articles and clinical guidelines on CML ..." | ||
| Vol 16, No 1 (2023) | Clinical approbation today: analysis of current problems and solutions | Abstract similar documents |
| V. V. Omelyanovskiy, D. V. Lukyantseva, T. I. Alekseeva, Yu. V. Voropaeva, T. A. Tomilina, R. A. Teryan, A. O. Gadzhieva | ||
| "... methods for making an informed decision to include them in clinical guidelines and routine clinical ..." | ||
| Vol 16, No 3 (2023) | Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia | Abstract similar documents |
| A. A. Taube, T. V. Alexandrova, O. A. Demidova, M. V. Zhuravleva | ||
| "... for CAP to determine etiotropic therapy. According to the national Russian clinical guidelines, macrolides ..." | ||
| Vol 8, No 2 (2015) | SYSTEMATIC LITERATURE REVIEW ON CLINICAL EFFICACY AND SAFETY OF ALOGLIPTIN IN COMPARISON WITH VILDAGLIPTIN, LINAGLIPTIN, SAXAGLIPTIN AND SITAGLIPTIN IN ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS | Abstract similar documents |
| Georgii Rubenovich Khachatryan, Vladislav Sergeevich Dombrovskii | ||
| "... and sitagliptin are registered in the RF and included in both russian and international modern guidelines on T2DM ..." | ||
| Vol 17, No 1 (2024) | A clinical case of ectopic pregnancy with localization in the liver | Abstract similar documents |
| A. Е. Voynovskiy, О. A. Zaitseva, A. G. Solopova, D. V. Blinov, М. P. Malykh-Bakhtina, G. К. Bykobshchenko | ||
| "... The article describes a clinical case of ectopic pregnancy with localization in the liver ..." | ||
| Vol 16, No 4 (2023) | Peculiarities of real-world data application for health technology assessment in Asian countries | Abstract similar documents |
| B. B. Kondratyeva, F. V. Gorkavenko, V. V. Omelyanovskiy | ||
| "... of this direction, adopted regulations, developed methodological guidelines, promising areas of application ..." | ||
| Vol 9, No 1 (2016) | PROSPECTS FOR THE USE OF METHODS OF ECONOMIC EVALUATION AT THE STAGE OF PLANNING AND ORGANISATION OF CLINICAL TRIALS | Abstract similar documents |
| N. Z. Musina, V. V. Tarasov | ||
| "... and organization of clinical trials and considers the examples of studies which undertook this approach. The use ..." | ||
| Vol 6, No 2 (2013) | HTA CORE MODEL | Abstract similar documents |
| R. I. Yagudina, T. Yu. Nor, A. D. Sevostyanov | ||
| "... .). Программное обеспечение Базовой Модели все еще находится в процессе разработки, как и методика проведения ..." | ||
| Vol 18, No 1 (2025) | Trends in the industry of clinical trials | Abstract similar documents |
| S. S. Milovanov, V. V. Popov, N. V. Teplova | ||
| "... Background. The clinical trial (CT) industry is subject to changes, some of which are rapidly ..." | ||
| Vol 14, No 1 (2021) | Clinical and economic constituents of the application of dexamethasone and tocilizumab in the therapy for severe conditions in patients with COVID-19 | Abstract similar documents |
| O. V. Zhukova, A. L. Khokhlov | ||
| "... of clinical and economic constituents of the application of an IL-6 inhibitor tocilizumab and systemic ..." | ||
| Vol 15, No 3 (2022) | The role of real world data and real world evidence in health technology assessment | Abstract similar documents |
| E. A. Novoderezhkina, S. К. Zyryanov | ||
| "... , health technology assessment (HTA) agencies, and by the clinical and scientific communities. However ..." | ||
| Vol 14, No 2 (2021) | Pharmacoeconomic aspects of oral vinorelbine application: a budget impact analysis considering the new registered price | Abstract similar documents |
| D. A. Ivanov, I. N. Dyakov, S. K. Zyryanov | ||
| "... of maximum selling prices, clinical guidelines for the studied nosologies, and instructions for medical use ..." | ||
| Vol 17, No 1 (2024) | Changes in patient recruitment parameters and their derivatives under the influence of external factors – population size and density of residence in a certain area | Abstract similar documents |
| S. S. Milovanov | ||
| "... Background. The lack of targeted patient recruitment for clinical trials reaches 90%, which leads ..." | ||
| Vol 18, No 1 (2025) | The effectiveness of using artificial intelligence in clinical medicine | Abstract similar documents |
| D. I. Korabelnikov, A. I. Lamotkin | ||
| "... Objective: To examine the effectiveness of using artificial intelligence (AI) in clinical medicine ..." | ||
| Vol 17, No 4 (2024) | Economic effectiveness of fixed-dose combination of alogliptin and pioglitazone in diabetes mellitus treatment | Abstract similar documents |
| S. К. Zyryanov, I. N. Dyakov | ||
| "... results of phase III clinical trials and clinical guidelines. Drug pricing information was derived from ..." | ||
| Vol 9, No 3 (2016) | EARLY HEALTH TECHNOLOGIES ASSESSMENT — NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS | Abstract similar documents |
| N. Z. Musina, V. V. Omelyanovskiy, A. V. Krasheninnikova | ||
| "... of the life cycle of medical technology. This method allows us to optimize the design of clinical trials ..." | ||
| Vol 9, No 3 (2016) | DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY | Abstract similar documents |
| M. V. Avxentyeva, V. I. Bogin, E. V. Derkach, V. V. Omelyanovskiy, M. B. Stenina, A. V. Tarakanov, M. Yu. Frolov | ||
| "... , клинические рекомендации. Результаты. Количество препаратов, закупленных для больных РМЖ, варьировало в ..." | ||
| Vol 12, No 1 (2019) | Evaluation of the clinical efficacy of anti-asthma pharmacotherapy in children using the software package based on the Fishburn method | Abstract similar documents |
| O. V. Zhukova, I. V. Nikiforova | ||
| "... Aim: to assess the clinical efficacy of pharmacotherapy regimens using a software package ..." | ||
| Vol 14, No 3 (2021) | History of controlled trials in medicine: real priorities are little-known. Report 2. From early experiments to the present day: without alternation and randomization | Abstract similar documents |
| A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov | ||
| "... The aim of the three-report review is the historical development of clinical trials, controlled ..." | ||
| Vol 17, No 3 (2024) | Artificial intelligence: basic terms and concepts, the application in healthcare and clinical medicine | Abstract similar documents |
| A. I. Lamotkin, D. I. Korabelnikov, I. A. Lamotkin | ||
| "... Objective: to explore the potential and challenges of artificial intelligence (AI) in clinical ..." | ||
| Vol 14, No 1 (2021) | History of controlled trials in medicine: real priorities are little-known. Report 1. Basic concepts, terms, and disciplines that use medical experiment: historical and philosophical sources | Abstract similar documents |
| A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov | ||
| "... The three-report review was aimed at describing the historical development of clinical trials ..." | ||
| Vol 7, No 3 (2014) | PHARMACOECONOMIC ANALYSIS OF THE USE OF OXALIPLATIN CHEMOTHERAPY FOR COLORECTAL CANCER.REAL (ACTUAL) CLINICAL PRACTICE DATA | Abstract similar documents |
| A. V. Pavlysh, A. S. Kolbin, A. R. Kasimova | ||
| "... State Health Care Institution «City Clinical Oncology Dispensary» in 2008-2010 was done ..." | ||
| Vol 14, No 3 (2021) | Pharmacoeconomic features of drug provision to the rheumatology department of the republican clinical hospital | Abstract similar documents |
| L. N. Sheikhmambetova, E. A. Egorova, K. N. Onishchenko, E. I. Konyaeva | ||
| "... to the rheumatology department of the state clinical hospital. Material and methods. The materials of the study ..." | ||
| Vol 10, No 2 (2017) | ECONOMIC ASSESSMENT OF THE EFFECTIVENESS AND SAFETY OF THE COMMONLY PRACTICED PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS (BASED ON AN EARLIER EPIDEMIOLOGICAL SURVEY OF MULTIDISCIPLINARY HOSPITALS) | Abstract similar documents |
| Yu. M. Gomon, A. S. Kolbin, S. V. Sidorenko, A. M. Kuzhel’, A. V. Repina, Yu. V. Lobzin, Yu. E. Balykina | ||
| "... to the clinical practice guidelines was 3.5 times less than that associated with the PAP used in the common ..." | ||
| Vol 17, No 2 (2024) | Approaches to determining the cost of laboratory tests | Abstract similar documents |
| I. I. Khayrullin, V. V. Omelyanovskiy, R. V. Gostishchev, O. A. Sukhorukikh, S. A. Kovaleva, B. G. Gorodetsky | ||
| "... of economic analysis and management of clinical diagnostic laboratories. Information about costs allows ..." | ||
| Vol 14, No 4 (2021) | History of controlled trials in medicine: real priorities are little-known. Report 3. Quasi-randomized and randomized trials in humans and animals | Abstract similar documents |
| A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov | ||
| "... The three-report review is aimed to describe the historical development of clinical trials ..." | ||
| Vol 17, No 4 (2024) | Biologically active supplements: safety, efficacy, market review | Abstract similar documents |
| A. M. Stepanova, А. N. Plutnitskiy, E. V. Gameeva | ||
| Vol 16, No 2 (2023) | Real-world data: principles of use in decision making and in health technology assessment | Abstract similar documents |
| V. V. Omelyanovskiy, F. V. Gorkavenko, N. V. Ignatyeva, P. A. Mukhortova, O. R. Ryzhova, T. S. Teptsova, A. A. Kingshott, B. B. Kondratyeva | ||
| "... , classification of RWE sources, position of RWD studies in the hierarchy of clinical study designs, as well ..." | ||
| Vol 11, No 4 (2018) | Clinical and economic studies on pharmacotherapy of malignant neoplasms: the modeling approach | Abstract similar documents |
| A. G. Tolkushin, S. K. Zyryanov, N. L. Pogudina, M. V. Davydovskaya | ||
| "... The aim is to develop a generalized algorithm and methodology for conducting clinical and economic ..." | ||
| Vol 7, No 1 (2014) | EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE | Abstract similar documents |
| M. N. Kostyleva, Yu. B. Belousov, A. N. Gratsianskaya, S. S. Postnikov | ||
| "... the present review is devoted to an actual problem of safety of pharmacotherapy in clinical ..." | ||
| Vol 14, No 2 (2021) | Artificial intelligence in healthcare: possibilities of patent protection | Abstract similar documents |
| T. N. Erivantseva, Yu. V. Blokhina | ||
| Vol 14, No 3 (2021) | The concept of syndromic diagnoses of osteoarthritis and back pain as a cause of therapy failure | Abstract similar documents |
| M. V. Putilina, N. V. Teplova, O. S. Gerasimova | ||
| "... the prevalence and treatment of back pain. Traditionally, clinical guidelines from various countries are devoted ..." | ||
| Vol 14, No 4 (2021) | Features of intellectual property protection mechanisms on the example of orphan drugs circulation | Abstract similar documents |
| D. S. Yurochkin, К. V. Nasonova, Z. М. Golant, I. А. Narkevich, V. P. Trukhin | ||
| "... and volume of clinical guidelines and to determine in advance the sources of financing and mechanisms ..." | ||
| Vol 16, No 2 (2023) | Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025 | Abstract similar documents |
| V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova | ||
| "... Background. In 2021, new clinical guidelines for the treatment of chronic hepatitis C virus (HCV ..." | ||
| Vol 5, No 3 (2012) | CLINICAL AND ECONOMIC BENEFITS OF HUMAN INSULIN ANALOGUESUSE | Abstract similar documents |
| E. E. Arinina, M. A. Rashyd | ||
| Vol 8, No 1 (2015) | PHARMACOEPIDEMIOLOGICAL EVALUATION OF HEPATOTROPIC THERAPY IN REAL CLINICAL PRACTICE | Abstract similar documents |
| D. V. Blinov, U. V. Zimovina, T. I. Ushakova | ||
| "... (ЭФЛ) в качестве гепатотропной терапии широко распространено в России. Однако в клинической практике ..." | ||
| Vol 7, No 3 (2014) | THE ANALYSIS OF METHODOLOGIC CHARACTERISTICS OF RESEARCHES ON SOCIAL AND ECONOMIC BURDEN OF DISEASES IN RUSSIA IN THE FRAMES OF DEVELOPMENT OF STANDARD COST OF ILLNESS METHODOLOGY FOR THE HEALTH TECHNOLOGY ASSESSMENT | Abstract similar documents |
| V. I. Ignatyeva, M. V. Avxentyeva | ||
| "... and national guidelines and publications devoted to the methodological issues of the cost of illness methods ..." | ||
| Vol 11, No 1 (2018) | Antimicrobial therapy of community-acquired pneumonia in a hospital setting (clinical and economic aspects) | Abstract similar documents |
| O. V. Zhukova, O. V. Ruina, M. V. Khazov, S. V. Romanov | ||
| "... The aim is to study the clinical and economic components of antimicrobial therapy (AMT ..." | ||
| Vol 11, No 3 (2018) | Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies | Abstract similar documents |
| T. S. Teptsova, T. P. Bezdenezhnyh, V. K. Fedyaeva, N. Z Musina, G. R. Hachatryan, V. V. Tarasov | ||
| "... to clinical and economic analysis, medical technologies with the incremental cost-effectiveness indicator ..." | ||
| Vol 15, No 2 (2022) | Pharmacoeconomic analysis of the use of a fixed combination of tiotropium bromide and olodaterol as maintenance therapy in patients with chronic obstructive pulmonary disease in the Russian Federation | Abstract similar documents |
| S. К. Zyryanov, I. N. Dyakov | ||
| Online First | Osteoarthritis therapy misconcepts | Abstract similar documents |
| O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
| "... and standards. In Russia, physicians are to follow MHRF clinical guidelines and standards for OA therapy. ..." | ||
| Vol 16, No 2 (2023) | From misconceptions to reasonable osteoarthritis patients therapy | Abstract similar documents |
| O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
| "... and MHRF clinical recommendations and standards. In Russia, physicians must follow MHRF clinical guidelines ..." | ||
| Vol 13, No 4 (2020) | Meta-analysis of clinical trials of osteoarthritis treatment effectiveness with Chondroguard | Abstract similar documents |
| I. Yu. Torshin, A. M. Lila, A. V. Naumov, A. Yu. Kochish, L. I. Alekseeva, E. A. Taskina, I. V. Sarvilina, A. N. Galustyan, A. N. Gromov, A. K. Khadzhidis, L. V. Vasilieva, E. F. Yevstratova, M. I. Udovika, O. A. Gromova | ||
| "... according to tie fixed-effects model included all published clinical studies on tie efficacy and safety ..." | ||
| 1 - 50 of 279 Items | 1 2 3 4 5 6 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
